SCHEMBL19863530

SCHEMBL19863530

Cc1ccc(-n2c3ccccc3c3cc4c(cc32)c2ccccc2n4-c2ccc(-n3c4ccccc4c4ccccc43)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
ATM Q13315 1/20 0.57
HTT P42858 3/20 0.47
MAPT P10636 2/20 0.47
LMNA P02545 1/20 0.47
METAP2 P50579 1/20 0.41
GPR3 P46089 1/20 0.40
AKR1C4 P17516 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KMT2A Q03164 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
POLB P06746 2/20 0.39
LIG1 P18858 1/20 0.38
TP53 P04637 2/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL551619 1.00 KDM4E (0.57) KDM4EL3MBTL1ATMHTTMAPT
SCHEMBL15451725 0.96 KDM4E (0.64) KDM4EL3MBTL1ATMHTTMAPT
SCHEMBL18416291 0.95 KDM4E (0.52) KDM4EL3MBTL1ATMHTTMAPT
SCHEMBL19769423 0.94 KDM4E (0.55) KDM4EL3MBTL1ATMHTTMAPT
SCHEMBL14313954 0.94 KDM4E (0.55) KDM4EL3MBTL1ATMHTTMAPT
SCHEMBL31373768 0.92 KDM4E (0.67) KDM4EL3MBTL1ATMHTTMAPT
SCHEMBL29110 0.92 KDM4E (0.67) KDM4EL3MBTL1ATMHTTMAPT
SCHEMBL14315075 0.92 KDM4E (0.48) KDM4EL3MBTL1ATMHTTMAPT
SCHEMBL10210242 0.91 KDM4E (0.52) KDM4EL3MBTL1ATMHTTMAPT
SCHEMBL15451828 0.91 KDM4E (0.62) KDM4EL3MBTL1ATMHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device SAMSUNG SDI CO., LTD. (KR) 2020-03-24 US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 US disclosed
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10600971-B2 Composition for organic optoelectric device and organic optoelectric device and display device OXER1, OR10J3, OR51E2 KDM4E 4718/4885L3MBTL1 4752/4885ATM 4443/4885
US-20180047916-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OR51E2 KDM4E 4718/4885L3MBTL1 4752/4885ATM 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.